Aer Therapeutics
About:
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Website: https://aertherapeutics.com/
Top Investors: OrbiMed, Hatteras Venture Partners, Canaan Partners
Description:
Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.
Total Funding Amount:
$36M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Raleigh, North Carolina, United States
Founded Date:
2014-01-01
Founders:
John Fahy
Number of Employees:
1-10
Last Funding Date:
2023-04-13
IPO Status:
Private
Industries:
© 2025 bioDAO.ai